Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study (Q46718636)

24 December 2017

title

Leptin links with plasminogen activator inhibitor-1 in human obesity: the SABPA study (English)

1 reference

24 December 2017

0 references

Aletta E Schutte

3

0 references

author name string

Chiné Pieterse

series ordinal

1

1 reference

24 December 2017

Rudolph Schutte

series ordinal

2

1 reference

24 December 2017

publication date

5 March 2015

1 reference

24 December 2017

published in

Hypertension Research

1 reference

24 December 2017

volume

38

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

507-512

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/hr.2015.28

exact match

0 references

cites work

Obesity in South Africa.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Global nutrition transition and the pandemic of obesity in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Structural and functional alterations of subcutaneous small resistance arteries in severe human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin-induced endothelial dysfunction: a target for therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin-induced endothelial dysfunction in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Estimating laboratory precision of urinary albumin excretion and other urinary measures in the International Study on Macronutrients and Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Relationship between IL-6, leptin and adiponectin and variables of fibrinolysis in overweight and obese hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin increase is associated with markers of the hemostatic system in obese healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Circulating adipocytokines and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Microalbuminuria and the metabolic syndrome in non-diabetic black Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Autonomic activity and leptin in Africans and whites: the SABPA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Enhancement of PAI-1 mRNA in cardiovascular cells after kainate injection is mediated through the sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Cyclic strain-induced plasminogen activator inhibitor-1 (PAI-1) release from endothelial cells involves reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

PAI-1, progress in understanding the clinical problem and its aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

von Willebrand factor, endothelial dysfunction, and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Progression of cardiovascular and endocrine dysfunction in a rabbit model of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Changes in serum aldosterone are associated with changes in obesity-related factors in normotensive overweight and obese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

von Willebrand factor plasma levels, genetic variations and coronary heart disease in an older population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Plasma leptin: Associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2015.28

Leptin induces oxidative stress in human endothelial cells.

21 January 2018

1 reference

12 December 2020

Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis

1 reference

12 December 2020

Leptin-induced endothelial dysfunction is mediated by sympathetic nervous system activity

1 reference

12 December 2020

Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents

1 reference

12 December 2020

Body mass index, leptin, and ambulatory blood pressure variability in healthy adults

1 reference

12 December 2020

Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults

1 reference

12 December 2020

von Willebrand factor is an acute phase reactant in man

1 reference

12 December 2020

Identifiers

DOI

10.1038/HR.2015.28

1 reference

24 December 2017

PubMed ID

25740294

1 reference

24 December 2017